EUVIMEDEUVIMED entdecken
Crossref

Simultaneous Determination of Levetiracetam, Sodium Valproate, and Olanzapine in Human Plasma by UPLC‐MS/MS for Therapeutic Drug Monitoring

Feng Zhou, Xinjun Cai, Chongyang Wu iD

Biomedical Chromatography · 2026-08 · 40 (8)

DOI: 10.1002/bmc.70536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 02.07.2026. Verfasst von Feng Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Levetiracetam, Valproic Acid, Drug Monitoring. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Zhejiang Science and Technology Plan for Disease Prevention and Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levetiracetam, sodium valproate, and olanzapine are widely used for epilepsy, but their therapeutic windows and pharmacokinetic variability require TDM. No existing method enables their simultaneous quantification. This study aimed to establish and validate a UPLC‐MS/MS method for their simultaneous detection in human plasma. Plasma samples were processed by protein precipitation. Chromatographic separation was achieved with gradient elution (3.0 min total time), and MRM mode was used for detection. The method showed good linearity ( R ≥ 0.9956), precision (CV ≤ 7.27%), and accuracy (bias: −8.95% ~ 9.17%). Extraction recoveries were 94.56%–103.98%, with negligible matrix effects. Application to 136 patients showed average concentrations within therapeutic ranges. This UPLC‐MS/MS method is rapid, accurate, and suitable for routine TDM of the three drugs, providing a reliable tool for individualized pharmacotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryLevetiracetamValproic AcidDrug MonitoringOlanzapineLiquid Chromatography-Mass SpectrometryAnticonvulsantsBenzodiazepinesHumansChromatography, High Pressure LiquidReproducibility of ResultsLinear ModelsLimit of DetectionFemaleMaleAdult

Stichwörter der Autor:innen

UPLC‐MS/MSantiepileptic drugshuman plasmasimultaneous quantificationtherapeutic drug monitoring

Substanzen

LevetiracetamValproic AcidOlanzapineAnticonvulsantsBenzodiazepines

Autor:innen und Institutionen

  • Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou, China.

ORCID-Profile: Chongyang Wu

Förderung

  • Zhejiang Science and Technology Plan for Disease Prevention and Control

Zitieren

APA

Zhou, F., Cai, X., & Wu, C. (2026). Simultaneous Determination of Levetiracetam, Sodium Valproate, and Olanzapine in Human Plasma by UPLC‐MS/MS for Therapeutic Drug Monitoring. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70536

Vancouver

Zhou F, Cai X, Wu C. Simultaneous Determination of Levetiracetam, Sodium Valproate, and Olanzapine in Human Plasma by UPLC‐MS/MS for Therapeutic Drug Monitoring. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70536

BibTeX
@article{Zhou2026,
  author = {Zhou, Feng and Cai, Xinjun and Wu, Chongyang},
  title = {Simultaneous Determination of Levetiracetam, Sodium Valproate, and Olanzapine in Human Plasma by UPLC‐MS/MS for Therapeutic Drug Monitoring},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1002/bmc.70536}
}
Kostenlos starten →